Category Uncategorized

Trump Admin Mulls Regulation of Direct-to-Consumer Pharma Ads

Debates within the Trump administration highlight growing discussions around introducing measures that could deter pharmaceutical firms from direct-to-consumer advertising. These potential policies could significantly impact the more than $10 billion invested annually in such advertising pursuits. Currently, the United States…